38 clinical trials matched your search for Breast Cancer. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Breast Cancer Study to Predict Your Therapeutic Response (I-SPY 2 Trial) Meghna Trivedi, MD
Breast Cancer Study Comparing Survival of Patients Monitored with Serum Tumor Marker Directed Disease Versus Usual Care in Metastatic Breast Cancer Melissa Accordino, MD
Breast Cancer Addinex-Opioid Dispenser for Post-Op Pain in Cancer Patients Dawn Hershman, MD
Breast Cancer Study of Symptom Monitoring using Young, Empowered & Strong (YES) Web Portal for Breast Cancer Survivors Dawn Hershman, MD
Breast Cancer Study of T-DM1 in Combination with Tucatinib for Patients with HER2-Positive Breast Cancer Julia McGuinness, MD
Breast Cancer Intervention to Improve Medication Scheduling for Patients with Breast Cancer Dawn Hershman, MD
Breast Cancer Study of RLY-2608 in Patients with Breast Cancer Julia McGuinness, MD
Breast Cancer Study of GLSI-100 in Female Patients with Breast Cancer Julia McGuinness, MD
Breast Cancer Study of Denosumab in Women with Breast Cancer who Carry the BRCA1 Mutation Katherine Crew, MD
Breast Cancer Study of Sacituzumab Govitecan (TRODELVY) in Patients with Triple-Negative Breast Cancer (TNBC) Meghna Trivedi, MD
Breast Cancer Study of Sacituzumab Govitecan in Combination with Pembrolizumab vs. Chemotherapy in Patients with Advanced Triple-Negative Breast Cancer Meghna Trivedi, MD
Breast Cancer Study of Breast Cancer in Black Women Lauren Houghton, PhD
Breast Cancer Study of Breast Cancer in Black Women - Healthy Controls Lauren Houghton, PhD
Breast Cancer Improving Medication Barriers Among Patients with Metastatic Breast Cancer Claire Sathe, MD
Breast Cancer Impact of Aromatase Inhibitors on Daily Activities for Individuals with Breast Cancer Rochelle Mendonca, PhD
Cancer Identification of Targets for Cancer Treatment Andrea Califano, PhD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Catherine Shu, MD
Cancer Study of IMC-F106C Alone and in Combination With Checkpoint Inhibitors in Participants with Advanced Cancers Benjamin Izar, MD
Cancer Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of BAY 1895344 in Combination with Chemotherapy for Patients with Advanced Cancer Mark Stein, MD
Cancer Study of Financial Navigator Addressing Cancer-Related Financial Hardship in Cancer Patients and Their Spouses Dawn Hershman, MD
Cancer Study of RP-3500 in Combination with PARP Inhibitor for Patients with Advanced Cancer Benjamin Herzberg, MD
Cancer Study of IDE397 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Hua-Jay Cherng, MD
Cancer Study of BT7480 in Patients with Advanced Cancer Mark Stein, MD
Cancer Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation Benjamin Herzberg, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of E-602 Alone or in Combination with Libtayo (Cemiplimab) in Patients with Advanced Cancer Brian Henick, MD
Cancer Study of BLU-222 Alone or in Combination with Other Cancer Therapy for Patients with Advanced Cancer Brian Henick, MD
Cancer Study of LNS8801 Alone or in Combination with Pembrolizumab in Patients with Advanced Cancer Brian Henick, MD
Cancer Study of RMC-6291 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Lung Cancer Study of Patritumab Deruxtecan in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Cancer Study of MRT-2359 in Patients with Solid Tumors Benjamin Herzberg, MD
Cancer Study of RMC-6236 in Patients with Solid Tumors with a KRAS Mutation Benjamin Herzberg, MD
Cancer Study of NDI-101150 Alone or in Combination with Pembrolizumab in Patients with Solid Tumors Ryan Moy, MD
Cancer Study of XmAb808 in Combination with Pembrolizumab in Patients with Advanced Cancer Mark Stein, MD
Cancer Cooling and Compression to Prevent Nerve Damage During Chemotherapy Melissa Accordino, MD
Cancer Study of HRO761 Alone or in Combination with Tislelizumab or Irinotecan in Patients with Solid Tumors Edmond Chan, MD